The addition of Sitaglyn and Siglyn to our diabetes portfolio will give patients access to a world-class oral therapy to help people manage their diabetes
Transcatheter Mitral valve procedure allows intervention on patients who are unsuitable or high risk for open heart surgery
The award was presented to her during a virtual ceremony on the occasion of 8th International Day of Yoga on 21st June 2022.
HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA in the United States
105 million 30 µg, 10 µg and 3 µg doses to be delivered into Q4 2022, with an option for the U.S. Government to purchase up to 195 million additional doses
First and only PARP inhibitor to improve invasive disease-free survival in patients
Silo enters into commercial evaluation license agreement for next generation liposomes
Tabrecta is the number one prescribed targeted therapy for advanced NSCLC with alterations leading to METex14 skipping globally
Intended for potential treatment of ER+/HER2- advanced or metastatic breast cancer patients
The array available for a subscription includes popular products to make menstrual hygiene a regular practice and extend further affordability to its users
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
